RECRUITINGOBSERVATIONAL
Fluciclovine PET/CT in Multiple Myeloma Patients
PET i Diagnostikk og Behandlingsrespons av Pasienter Med Myelomatose
About This Trial
Comparison between image findings at aminoacid PET/CT and FDG PET/CT for myeloma patients
Who May Be Eligible (Plain English)
Who May Qualify:
- Multiple myeloma patients suitable for ASCT treatment
Who Should NOT Join This Trial:
- Patients with contraindications to ASCT treatment
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Multiple myeloma patients suitable for ASCT treatment
Exclusion Criteria:
* Patients with contraindications to ASCT treatment
Locations (1)
Oslo University Hosptal
Oslo, Norway